Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity.

Jia Q, Ng Q, Chin W, Meng T, Chow VTK, Wang CI, Kwang J, He F.

Sci Rep. 2017 Apr 19;7:46402. doi: 10.1038/srep46402.

2.

Antiviral activity of acid beta-glucosidase 1 on enterovirus 71, a causative agent of hand, foot and mouth disease.

Nakata K, Takeda S, Tanaka A, Kwang J, Komano J.

J Gen Virol. 2017 Apr;98(4):643-651. doi: 10.1099/jgv.0.000723. Epub 2017 Apr 22.

PMID:
28141506
3.

Transcriptome analysis of genes responding to NNV infection in Asian seabass epithelial cells.

Liu P, Wang L, Kwang J, Yue GH, Wong SM.

Fish Shellfish Immunol. 2016 Jul;54:342-52. doi: 10.1016/j.fsi.2016.04.029. Epub 2016 Apr 21.

PMID:
27109582
4.

Pneumococcal Pneumolysin Induces DNA Damage and Cell Cycle Arrest.

Rai P, He F, Kwang J, Engelward BP, Chow VT.

Sci Rep. 2016 Mar 30;6:22972. doi: 10.1038/srep22972.

5.

Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines.

Ng Q, He F, Kwang J.

Viruses. 2015 Dec 8;7(12):6441-57. doi: 10.3390/v7122949. Review.

6.

Strategies towards universal pandemic influenza vaccines.

He F, Leyrer S, Kwang J.

Expert Rev Vaccines. 2016;15(2):215-25. doi: 10.1586/14760584.2016.1115352. Epub 2015 Dec 5. Review.

PMID:
26641724
7.

How can we develop universal H5N1 vaccines.

Tan Y, He F, Kwang J.

Immunotherapy. 2015;7(7):713-6. doi: 10.2217/imt.15.42. Epub 2015 Aug 7.

PMID:
26250411
8.

Streptococcus pneumoniae secretes hydrogen peroxide leading to DNA damage and apoptosis in lung cells.

Rai P, Parrish M, Tay IJ, Li N, Ackerman S, He F, Kwang J, Chow VT, Engelward BP.

Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3421-30. doi: 10.1073/pnas.1424144112. Epub 2015 Jun 15.

9.

Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge.

Kumar SR, Prabakaran M, Ashok Raj KV, He F, Kwang J.

PLoS One. 2015 Jun 1;10(6):e0128940. doi: 10.1371/journal.pone.0128940. eCollection 2015.

10.

A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.

Tan Y, Ng Q, Jia Q, Kwang J, He F.

J Virol. 2015 Apr;89(7):3712-22. doi: 10.1128/JVI.03014-14. Epub 2015 Jan 21.

11.

Progress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine.

Prabakaran M, Leyrer S, He F, Auer S, Kumar SR, Kindsmueller K, Mytle N, Schneider J, Lockhart S, Kwang J.

PLoS One. 2014 Sep 17;9(9):e107316. doi: 10.1371/journal.pone.0107316. eCollection 2014.

12.

Reprint of "evolution of specific immunity in shrimp - a vaccination perspective against white spot syndrome virus".

Syed Musthaq SK, Kwang J.

Dev Comp Immunol. 2015 Feb;48(2):342-53. doi: 10.1016/j.dci.2014.07.016. Epub 2014 Jul 30. Review.

PMID:
25083808
13.

Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.

Prabakaran M, Kumar SR, Raj KV, Wu X, He F, Zhou J, Kwang J.

Antiviral Res. 2014 Sep;109:149-59. doi: 10.1016/j.antiviral.2014.06.017. Epub 2014 Jul 2.

PMID:
24997413
14.

Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.

Musthaq SK, Kumar SR, Szyporta M, Kwang J.

Antiviral Res. 2014 Sep;109:42-53. doi: 10.1016/j.antiviral.2014.06.002. Epub 2014 Jun 25.

PMID:
24973759
15.

Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column.

Kattur Venkatachalam AR, Szyporta M, Kiener TK, Balraj P, Kwang J.

Virol J. 2014 May 27;11:99. doi: 10.1186/1743-422X-11-99.

16.

A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.

Kiener TK, Jia Q, Meng T, Chow VT, Kwang J.

PLoS Negl Trop Dis. 2014 May 29;8(5):e2895. doi: 10.1371/journal.pntd.0002895. eCollection 2014.

17.

Evolution of specific immunity in shrimp - a vaccination perspective against white spot syndrome virus.

Syed Musthaq SK, Kwang J.

Dev Comp Immunol. 2014 Oct;46(2):279-90. doi: 10.1016/j.dci.2014.04.013. Epub 2014 Apr 26. Review.

PMID:
24780624
18.

Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.

He F, Prabakaran M, Rajesh Kumar S, Tan Y, Kwang J.

Antiviral Res. 2014 May;105:143-51. doi: 10.1016/j.antiviral.2014.03.002. Epub 2014 Mar 15.

PMID:
24637255
19.

Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice.

Meng T, Kwang J.

J Virol. 2014 May;88(10):5803-15. doi: 10.1128/JVI.00289-14. Epub 2014 Mar 12.

20.

Immune responses of orange-spotted grouper, Epinephelus coioides, against virus-like particles of betanodavirus produced in Escherichia coli.

Lai YX, Jin BL, Xu Y, Huang LJ, Huang RQ, Zhang Y, Kwang J, He JG, Xie JF.

Vet Immunol Immunopathol. 2014 Jan 15;157(1-2):87-96. doi: 10.1016/j.vetimm.2013.10.003. Epub 2013 Oct 18.

PMID:
24252246
21.

Development of dual-function ELISA for effective antigen and antibody detection against H7 avian influenza virus.

He F, Prabakaran M, Tan Y, Indira K, Kumar SR, Kwang J.

BMC Microbiol. 2013 Oct 2;13:219. doi: 10.1186/1471-2180-13-219.

22.

A novel baculovirus vector shows efficient gene delivery of modified porcine reproductive and respiratory syndrome virus antigens and elicits specific immune response.

Karuppannan AK, Qiang J, Chang CC, Kwang J.

Vaccine. 2013 Nov 4;31(46):5471-8. doi: 10.1016/j.vaccine.2013.08.101. Epub 2013 Sep 12.

PMID:
24035590
23.

Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virus.

He F, Kumar SR, Syed Khader SM, Tan Y, Prabakaran M, Kwang J.

Antiviral Res. 2013 Oct;100(1):207-14. doi: 10.1016/j.antiviral.2013.08.003. Epub 2013 Aug 13.

PMID:
23954322
24.

Recombinant baculovirus displayed vaccine: a novel tool for the development of a cross-protective influenza H5N1 vaccine.

Prabakaran M, Kwang J.

Bioengineered. 2014 Jan-Feb;5(1):45-8. doi: 10.4161/bioe.26001. Epub 2013 Aug 9.

25.

Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus.

Rajesh Kumar S, Syed Khader SM, Kiener TK, Szyporta M, Kwang J.

PLoS One. 2013 Jun 7;8(6):e63856. doi: 10.1371/journal.pone.0063856. Print 2013.

26.

Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen.

Kiener TK, Premanand B, Kwang J.

Expert Rev Vaccines. 2013 Apr;12(4):357-64. doi: 10.1586/erv.13.18.

PMID:
23560917
27.

Monoclonal Antibody Targeting Neutralizing Epitope on H5N1 Influenza Virus of Clade 1 and 0 for Specific H5 Quantification.

He F, Kwang J.

Influenza Res Treat. 2013;2013:360675. doi: 10.1155/2013/360675. Epub 2013 Mar 5.

28.

Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice.

Premanand B, Prabakaran M, Kiener TK, Kwang J.

PLoS One. 2013;8(2):e55536. doi: 10.1371/journal.pone.0055536. Epub 2013 Feb 4.

29.

Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains.

He F, Kiener TK, Lim XF, Tan Y, Raj KV, Tang M, Chow VT, Chen Q, Kwang J.

PLoS One. 2013;8(1):e55517. doi: 10.1371/journal.pone.0055517. Epub 2013 Jan 31.

30.

Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge.

Prabakaran M, Kolpe AB, He F, Kwang J.

Vaccine. 2013 Feb 27;31(10):1385-92. doi: 10.1016/j.vaccine.2013.01.003. Epub 2013 Jan 14.

PMID:
23328313
31.

Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein.

Lim XF, Jia Q, Chow VT, Kwang J.

J Virol Methods. 2013 Mar;188(1-2):76-82. doi: 10.1016/j.jviromet.2012.11.038. Epub 2012 Dec 7.

PMID:
23219932
32.

GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation.

Chen Q, He F, Kwang J, Chan JK, Chen J.

J Immunol. 2012 Dec 1;189(11):5223-9. doi: 10.4049/jimmunol.1201789. Epub 2012 Oct 22.

33.

RNA polymerase I-driven reverse genetics system for enterovirus 71 and its implications for vaccine production.

Meng T, Kiener TK, Kwang J.

Virol J. 2012 Oct 17;9:238. doi: 10.1186/1743-422X-9-238.

34.

Sf-PHB2, a new transcription factor, drives WSSV Ie1 gene expression via a 12-bp DNA element.

Ma G, Yu L, Wang Q, Liu W, Cui Y, Kwang J.

Virol J. 2012 Sep 17;9:206. doi: 10.1186/1743-422X-9-206.

35.

Identification and characterization of a monoclonal antibody recognizing the linear epitope RVADVI on VP1 protein of enterovirus 71.

Man-Li T, Szyporta M, Fang LX, Kwang J.

J Med Virol. 2012 Oct;84(10):1620-7. doi: 10.1002/jmv.23372.

PMID:
22930511
36.

Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.

Kolpe AB, Kiener TK, Grotenbreg GM, Kwang J.

Virus Res. 2012 Sep;168(1-2):64-72. doi: 10.1016/j.virusres.2012.06.014. Epub 2012 Jun 20.

PMID:
22728446
37.

Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1.

Premanand B, Kiener TK, Meng T, Tan YR, Jia Q, Chow VT, Kwang J.

Antiviral Res. 2012 Sep;95(3):311-5. doi: 10.1016/j.antiviral.2012.05.017. Epub 2012 Jun 9.

PMID:
22691220
38.

Natural compounds inhibiting the replication of Porcine reproductive and respiratory syndrome virus.

Karuppannan AK, Wu KX, Qiang J, Chu JJ, Kwang J.

Antiviral Res. 2012 May;94(2):188-94. doi: 10.1016/j.antiviral.2012.03.008. Epub 2012 Apr 3.

PMID:
22487208
39.

Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.

Kiener TK, Jia Q, Lim XF, He F, Meng T, Chow VT, Kwang J.

Virol J. 2012 Feb 24;9:55. doi: 10.1186/1743-422X-9-55.

40.

Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection.

Lim XF, Jia Q, Khong WX, Yan B, Premanand B, Alonso S, Chow VT, Kwang J.

PLoS One. 2012;7(1):e29751. doi: 10.1371/journal.pone.0029751. Epub 2012 Jan 18.

41.

Characterization of a monoclonal antibody against the 3D polymerase of enterovirus 71 and its use for the detection of human enterovirus A infection.

Kiener TK, Lim XF, Jia Q, Meng T, Chow VT, Kwang J.

J Virol Methods. 2012 Mar;180(1-2):75-83. doi: 10.1016/j.jviromet.2011.12.015. Epub 2011 Dec 31.

PMID:
22226793
42.

Oral vaccination of baculovirus-expressed VP28 displays enhanced protection against White Spot Syndrome Virus in Penaeus monodon.

Syed MS, Kwang J.

PLoS One. 2011;6(11):e26428. doi: 10.1371/journal.pone.0026428. Epub 2011 Nov 1.

43.

Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice.

Prabakaran M, Meng T, He F, Yunrui T, Qiang J, Lin RT, Kwang J.

Clin Vaccine Immunol. 2011 Sep;18(9):1582-5. doi: 10.1128/CVI.05114-11. Epub 2011 Jul 13.

44.

Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice.

Meng T, Kolpe AB, Kiener TK, Chow VT, Kwang J.

PLoS One. 2011;6(7):e21757. doi: 10.1371/journal.pone.0021757. Epub 2011 Jul 1.

45.

Deletion of the aceE gene (encoding a component of pyruvate dehydrogenase) attenuates Salmonella enterica serovar Enteritidis.

Pang E, Tien-Lin C, Selvaraj M, Chang J, Kwang J.

FEMS Immunol Med Microbiol. 2011 Oct;63(1):108-18. doi: 10.1111/j.1574-695X.2011.00834.x. Epub 2011 Jul 29.

46.

A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses.

Velumani S, Ho HT, He F, Musthaq S, Prabakaran M, Kwang J.

PLoS One. 2011;6(6):e20737. doi: 10.1371/journal.pone.0020737. Epub 2011 Jun 10.

47.

Complementary monoclonal antibody-based dot ELISA for universal detection of H5 avian influenza virus.

He F, Soejoedono RD, Murtini S, Goutama M, Kwang J.

BMC Microbiol. 2010 Dec 30;10:330. doi: 10.1186/1471-2180-10-330.

48.

ORF3 of porcine circovirus 2 enhances the in vitro and in vivo spread of the of the virus.

Karuppannan AK, Kwang J.

Virology. 2011 Feb 5;410(1):248-56. doi: 10.1016/j.virol.2010.11.009. Epub 2010 Dec 8.

49.

Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.

Prabakaran M, He F, Meng T, Madhan S, Yunrui T, Jia Q, Kwang J.

J Virol. 2010 Nov;84(22):11822-30. doi: 10.1128/JVI.00891-10. Epub 2010 Sep 15.

50.

Baculovirus as vaccine vectors.

Madhan S, Prabakaran M, Kwang J.

Curr Gene Ther. 2010 Jun;10(3):201-13. Review.

PMID:
20394572

Supplemental Content

Support Center